Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644212 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS
A Phase 4 study of Vitamin D Deficiency and Polycystic Ovary Syndrome, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT03644212 is a Phase 4 study of Vitamin D Deficiency and Polycystic Ovary Syndrome that has completed, run by Maimonides Medical Center. The registered enrollment target is 79 participants, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03644212, a Phase 4 study of Vitamin D Deficiency and Polycystic Ovary Syndrome, has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the mechanism that explain the beneficial clinical effect of vitamin D treatment in women with PCOS.
Conditions Studied
Interventions
- DRUG Vitamin D3
Study Locations (1)
New York
- Maimonides Medical Center, OBGYN clinic - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03644212
The ClinicalTrials.gov registry entry for NCT03644212 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (71% lower). The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vitamin D Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT03644212 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03644212 about?
NCT03644212 is a clinical study titled "Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS". The purpose of this study is to investigate the mechanism that explain the beneficial clinical effect of vitamin D treatment in women with PCOS.
What is the current status of trial NCT03644212?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2012-07. Estimated completion is 2013-10.
What conditions does trial NCT03644212 study?
This clinical trial studies the following conditions: Vitamin D Deficiency, Polycystic Ovary Syndrome.
What interventions are being tested in trial NCT03644212?
The interventions under investigation include: Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT03644212?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03644212 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin D Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA)
ACTIVE NOT RECRUITING · Phase 4
-
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
ACTIVE NOT RECRUITING · Phase 4
-
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
COMPLETED · Phase 4
-
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
COMPLETED · Phase 4
-
Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
COMPLETED · Phase 4
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.